{"id":"NCT00516906","sponsor":"Solventum US LLC","briefTitle":"Clinical Performance of a Chlorhexidine Antimicrobial Dressing","officialTitle":"Clinical Performance of a Chlorhexidine Antimicrobial Dressing","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-10","primaryCompletion":"2007-12","completion":"2008-01","firstPosted":"2007-08-16","resultsPosted":"2012-02-23","lastUpdate":"2024-10-24"},"enrollment":68,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Catheterization"],"interventions":[{"type":"DRUG","name":"Chlorhexidine gluconate","otherNames":["3M(TM) Tegaderm(TM) CHG Dressing"]},{"type":"DRUG","name":"Transparent Adhesive Dressing","otherNames":["TAD, Polyurethane Dressing, Transparent Membrane Dressing"]}],"arms":[{"label":"Transparent Adhesive Dressing","type":"PLACEBO_COMPARATOR"},{"label":"CHG antimicrobial transparent dressing","type":"EXPERIMENTAL"}],"summary":"Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing","primaryOutcome":{"measure":"Clinician Overall Satisfaction With Catheter Securement","timeFrame":"Daily up to 7 Days (average 3-7 days of wear)","effectByArm":[{"arm":"Placebo Comparator: A","deltaMin":2.27,"sd":0.78},{"arm":"CHG Antimicrobial Transparent Dressing","deltaMin":1.63,"sd":1.63}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":30},"commonTop":["Elevated Temperature","Elevated WBC, No fever, culture negative","Intermittent confusion existing prior to start"]}}